Deutsche Bank Downgrades ResMed (RMD) to Hold

October 25, 2013 8:55 AM

Deutsche Bank downgraded ResMed (NYSE: RMD) from Buy to Hold with a price target of $54.00 (from $58.00). Analyst David ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found